A carregar...
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
The biology of atypical hemolytic uremic syndrome has been shown to involve inability to limit activation of the alternative complement pathway, with subsequent damage to systemic endothelial beds and the vasculature, resulting in the prototypic findings of a thrombotic microangiopathy. Central to t...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835139/ https://ncbi.nlm.nih.gov/pubmed/27110144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S36249 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|